Navigation Links
Ferndale and Foamix Execute License Agreement for Development of Non-Steroidal Foam for Atopic Dermatitis
Date:6/3/2008

Aim is to Target 46,000,000 Atopic Patients Worldwide

FERNDALE, Michigan and NESS ZIONA, Israel, June 3 /PRNewswire/ -- Ferndale Laboratories Inc. and Foamix Ltd. announced today that the two companies executed a license agreement for Ferndale to develop and commercialize non-steroidal foam for the treatment of atopic dermatitis and eczema.

The agreement was signed following Foamix's successful development of non-steroidal foam which is designed to help skin barrier properties. Under the terms of the agreement, Foamix will be entitled to receive milestone payments upon achievement of various developments and commercial events and double-digit royalties.

"We are pleased to announce this license agreement with Foamix. Foamix has a proven track record of developing innovative dermatological foams and we are confident that this innovative product is a valuable addition to Ferndale's medications portfolio." said James T. McMillan II, Chief Executive Officer of, Ferndale.

Atopic Dermatitis (AD) is a common chronic inflammatory skin condition, affecting 15-20% of schoolchildren and 2-10% of adults. According to recent surveys, there are 17.8 million patients in the US and 46 million patients worldwide known to be affected. In the majority of patients, the disease begins in early childhood, often in the first year of life, when it can be particularly severe. The skin becomes extremely itchy; scratching leads to redness, swelling, cracking, "weeping" of clear fluid, and finally, crusting and scaling. The prolonged and continuous itching can lead to reduced attention, sustained sleep deprivation and scratching, which impairs the quality of life of the sufferer.

Poor adherence to AD therapy is common, and therefore, foams, which do not require extensive rubbing to achieve the necessary spreading and absorption, offer an improved treatment.

"This agreement with Ferndale further underscores Foamix's ability to convert techn
'/>"/>

SOURCE Foamix Ltd
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Ferndale and Foamix Enter Development of an Innovative Foam for the Treatment of Atopic Dermatitis
2. Foamix Signs Term Sheet to Acquire License to Organo-Boron Antifungal Molecules - Will Target the $11 Billion Dollars Fungal Infection Market
3. Diamyd Strengthens Financial Position and Executes a Fully Subscribed Direct Placement
4. Powersafe Technology Corp. Recapitalizes, Executes Merger Agreement with Amplification Technologies, and Invests in Amplification
5. Cepheid Market Reach Extended with Licenses in Canada and Registrations in Mexico
6. Santen and MacuSight Announce Collaboration and License Agreement for Sirolimus in Ocular Diseases and Conditions
7. BMP Sunstone Receives Import Drug License (IDL) from SFDA
8. Intellect Neurosciences, Inc. Grants License for Certain Patents and Patent Applications to Wyeth and Elan Pharma International Ltd.
9. Debiopharm Signs License Agreement for Marketing of Salvacyl(R)/Moapar(R) 3-Month in Treatment of Sexual Deviations
10. USGI Medical Licenses Incisionless Surgery Technology to Intuitive Surgical
11. Dalton Pharma Services Licenses Thermo Fisher Scientific Technology to Produce Polynucleotides for Drug Development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... January 22, 2015 zFlo Motion , ... to announce an exciting product from a new partner. ... solutions over the past 15 years, with offerings in the ... their 3D IMU system (inertial measurement unit), iSen, is opening ...
(Date:1/22/2015)... Denville, NJ (PRWEB) January 22, 2015 ... shearing technologies such as the Bioruptor® and complete ... semi-automation system for chromatin immunoprecipitation, alleviating the need ... reagents and controls needed for ChIP of histones ...
(Date:1/22/2015)... GenoSpace , a precision medicine software company that has developed ... of genomic, imaging and other biomedical data in research and ... , CEO of Aspera, an IBM Company, to its board ... "We are pleased to welcome Michelle ...
(Date:12/24/2014)... and NEW YORK , Dec. ... biopharmaceutical company advancing patient care in critical areas, announced the ... common stock, and warrants to purchase up to an aggregate ... $4.00 per share and $.01 per warrant.  The warrants have ...
Breaking Biology Technology:3D Motion Capture Just Got Easy 2Diagenode Launches Unique Semi-Automated Solution for Chromatin Immunoprecipitation 2GenoSpace Expands Board with Appointment of Michelle Munson 2PlasmaTech Biopharmaceuticals, Inc. Announces Closing of Public Offering 2PlasmaTech Biopharmaceuticals, Inc. Announces Closing of Public Offering 3
... 3, Rosetta Genomics Ltd (Nasdaq: ROSG ), a ... present Collins Stewart Fourth Annual Growth Conference on,Wednesday, July ... Hotel in New,York., About Rosetta Genomics, Rosetta ... the field of microRNA.,Founded in 2000, the company,s integrative ...
... TUSTIN, Calif., July 3 AMDL, Inc. (Amex:,ADL), ... Tustin,Ca., with operations in Shenzhen, Jiangxi, and Jilin, ... which is available for,viewing on the Company,s website ... AMDL, Inc. is a global specialty pharmaceutical company. ...
... July 2 Effective immediately, SpectraCell,Laboratories now ... using,its proprietary FIA(TM) (Functional Intracellular Analysis) technology.,This ... vitamin and mineral,deficiencies long before classic deficiency ... levels in patients has been climbing in ...
Cached Biology Technology:AMDL Announces Investor Relations Presentation Available on Website 2SpectraCell Laboratories Now Measures Vitamin C 2
(Date:12/17/2014)... DENVER , Dec. 16, 2014  Automation is fundamentally ... evident than at international borders. Over the past decade, ... veteran travelers to self process through border control via ... increasing number of airports, seaports, and land borders across ...
(Date:12/11/2014)... WINSTON SALEM, N.C. , Dec. 10, 2014  That blood ... for quite a while. Hypertension – the medical term for ... in the early 1800s, and the inflatable cuff that,s used ... That doesn,t, however, mean there,s nothing new about hypertension, its ...
(Date:12/10/2014)... , Dec. 9, 2014  Wake Forest Baptist Medical Center today ... School of Medicine. Funding for this $50 million capital project ... publicly launched next summer. The medical education ... Reynolds Tobacco Company complex, adjacent to 525@vine in Wake Forest ...
Breaking Biology News(10 mins):Automated Border Control (ABC) Transforms the Global Travel Experience With More Than 2500 ABC eGates and APC Kiosks Deployed In Airports, Seaports, and Land Borders Worldwide 2Research points to need for new approaches to treatment of high blood pressure 2Research points to need for new approaches to treatment of high blood pressure 3Research points to need for new approaches to treatment of high blood pressure 4Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 2Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 3Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 4
... animals living in the deep sea, it seems that there ... conditions, it,s generally best to be transparent. But in the ... function as searchlights, it,s much better to go in darker ... November 10 in Current Biology , a Cell Press ...
... The hermaphroditic cleaner shrimp Lysmata amboinensis usually ... structure. New research published in BioMed Central,s open access journal ... any group larger than two, viciously attack and kill each ... amboinensis are protandric simultaneous hermaphrodites. This means that they ...
... November 10, 2011 ─ (BRONX, NY) ─ Researchers ... Medicine of Yeshiva University have uncovered a mechanism that ... could have implications for human health and disease and ... journal Cell . A fundamental question ...
Cached Biology News:For deep-sea cephalopods, 'switchable' camouflage saves the day 2Violent passions jealous cleaner shrimp murder their rivals 2Einstein researchers discover key to cell specialization 2
...
... Dissociation Buffers are membrane-filtered isotonic and ... agents and cell-conditioning agents in either ... solution or Ca2+- and Mg2+-free ... mammalian cells from support substrates and ...
... Buffers are membrane-filtered isotonic and enzyme-free ... and cell-conditioning agents in either Ca2+- ... or Ca2+- and Mg2+-free phosphate-buffered ... cells from support substrates and each ...
... Antibody Modification Services ... including antibody labeling and antibody fragmentation. ... provides signals for visualization and quantitation ... assays, it is preferable to use ...
Biology Products: